--Sanofi is considering a potential acquisition of Mirati Therapeutics Inc., a San Diego-based biotechnology company focused on cancer drugs, Bloomberg reports, citing unnamed sources.

--Mirati could draw interest from other suitors and there is no certainty that the French pharmaceutical giant's deliberations will result in a deal, according to Bloomberg.

--Sanofi and Mirati didn't immediately respond to requests for comment from Dow Jones Newswires.

Full story: https://shorturl.at/lIR39

Write to Adria Calatayud at adria.calatayud@dowjones.com

(END) Dow Jones Newswires

October 06, 2023 02:41 ET (06:41 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Mirati Therapeutics (NASDAQ:MRTX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Mirati Therapeutics.
Mirati Therapeutics (NASDAQ:MRTX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Mirati Therapeutics.